Serum erythropoietin levels in term and preterm infants during the first year of life

Hironori Yamashita, Johji Kukita, Shoichi Ohga, Hideki Nakayama, Kouhei Akazawa, Kohji Ueda

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: To evaluate the kinetics of erythropoietin (EPO) production and address the pathogenesis of anemia of prematurity, we measured EPO levels in infants during the first year of life. Patients and Methods: Using a radioimmunoassay, serum EPO levels were measured in 97 infants classified into three groups according to weight: group A, n = 40, < 1,500 g; group B, n = 19, 1,500–2,499 g; and group C, n = 38, × 2,500 g. Results: The serum EPO level ranged widely during the early neonatal period from days 0 to 6 (group A, <5 to 307 mU/ml; group B, 10–340 mU/ml; and group C, 9–108 mU/ml). EPO reached its lowest level (<20 mU/ml) between days 7 and 50 in all groups. The hemoglobin concentration reached its nadir between days 51 and 150 in all groups, with the lowest concentration observed in low birth weight infants. In contrast, the EPO level during the anemic phase was ∼20 mU/ml and was independent of birth weight. A negative correlation between serum EPO level and hemoglobin concentration was observed only in group C (r = -0.54, p < 0.05). The negative slope of the regression equation in group C exceeded that of groups A and B (p < 0.05). When the relationship between EPO and Hb was evaluated over periods of 7–50 days, 51–100 days, and >101 days, respectively, we noted a significant correlation between values on days 7 and 50 in group A (r = -0.53, p < 0.05) and between days 51 and 100 in group B (r = -0.76, p< 0.05). Conclusions: These data suggest the appreciable EPO production in premature infants, but its insufficient response to the depressed hemoglobin level, implying the need to administer exogenous EPO to infants with anemia of prematurity.

Original languageEnglish
Pages (from-to)213-218
Number of pages6
JournalJournal of Pediatric Hematology/Oncology
Volume16
Issue number3
DOIs
Publication statusPublished - Jan 1 1994

Fingerprint

Erythropoietin
Premature Infants
Serum
Anemia
Radioimmunoassay
Hemoglobins
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Serum erythropoietin levels in term and preterm infants during the first year of life. / Yamashita, Hironori; Kukita, Johji; Ohga, Shoichi; Nakayama, Hideki; Akazawa, Kouhei; Ueda, Kohji.

In: Journal of Pediatric Hematology/Oncology, Vol. 16, No. 3, 01.01.1994, p. 213-218.

Research output: Contribution to journalArticle

Yamashita, Hironori ; Kukita, Johji ; Ohga, Shoichi ; Nakayama, Hideki ; Akazawa, Kouhei ; Ueda, Kohji. / Serum erythropoietin levels in term and preterm infants during the first year of life. In: Journal of Pediatric Hematology/Oncology. 1994 ; Vol. 16, No. 3. pp. 213-218.
@article{057ef6b6a5b445be9ef98454fa06696c,
title = "Serum erythropoietin levels in term and preterm infants during the first year of life",
abstract = "Purpose: To evaluate the kinetics of erythropoietin (EPO) production and address the pathogenesis of anemia of prematurity, we measured EPO levels in infants during the first year of life. Patients and Methods: Using a radioimmunoassay, serum EPO levels were measured in 97 infants classified into three groups according to weight: group A, n = 40, < 1,500 g; group B, n = 19, 1,500–2,499 g; and group C, n = 38, × 2,500 g. Results: The serum EPO level ranged widely during the early neonatal period from days 0 to 6 (group A, <5 to 307 mU/ml; group B, 10–340 mU/ml; and group C, 9–108 mU/ml). EPO reached its lowest level (<20 mU/ml) between days 7 and 50 in all groups. The hemoglobin concentration reached its nadir between days 51 and 150 in all groups, with the lowest concentration observed in low birth weight infants. In contrast, the EPO level during the anemic phase was ∼20 mU/ml and was independent of birth weight. A negative correlation between serum EPO level and hemoglobin concentration was observed only in group C (r = -0.54, p < 0.05). The negative slope of the regression equation in group C exceeded that of groups A and B (p < 0.05). When the relationship between EPO and Hb was evaluated over periods of 7–50 days, 51–100 days, and >101 days, respectively, we noted a significant correlation between values on days 7 and 50 in group A (r = -0.53, p < 0.05) and between days 51 and 100 in group B (r = -0.76, p< 0.05). Conclusions: These data suggest the appreciable EPO production in premature infants, but its insufficient response to the depressed hemoglobin level, implying the need to administer exogenous EPO to infants with anemia of prematurity.",
author = "Hironori Yamashita and Johji Kukita and Shoichi Ohga and Hideki Nakayama and Kouhei Akazawa and Kohji Ueda",
year = "1994",
month = "1",
day = "1",
doi = "10.1097/00043426-199408000-00005",
language = "English",
volume = "16",
pages = "213--218",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Serum erythropoietin levels in term and preterm infants during the first year of life

AU - Yamashita, Hironori

AU - Kukita, Johji

AU - Ohga, Shoichi

AU - Nakayama, Hideki

AU - Akazawa, Kouhei

AU - Ueda, Kohji

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Purpose: To evaluate the kinetics of erythropoietin (EPO) production and address the pathogenesis of anemia of prematurity, we measured EPO levels in infants during the first year of life. Patients and Methods: Using a radioimmunoassay, serum EPO levels were measured in 97 infants classified into three groups according to weight: group A, n = 40, < 1,500 g; group B, n = 19, 1,500–2,499 g; and group C, n = 38, × 2,500 g. Results: The serum EPO level ranged widely during the early neonatal period from days 0 to 6 (group A, <5 to 307 mU/ml; group B, 10–340 mU/ml; and group C, 9–108 mU/ml). EPO reached its lowest level (<20 mU/ml) between days 7 and 50 in all groups. The hemoglobin concentration reached its nadir between days 51 and 150 in all groups, with the lowest concentration observed in low birth weight infants. In contrast, the EPO level during the anemic phase was ∼20 mU/ml and was independent of birth weight. A negative correlation between serum EPO level and hemoglobin concentration was observed only in group C (r = -0.54, p < 0.05). The negative slope of the regression equation in group C exceeded that of groups A and B (p < 0.05). When the relationship between EPO and Hb was evaluated over periods of 7–50 days, 51–100 days, and >101 days, respectively, we noted a significant correlation between values on days 7 and 50 in group A (r = -0.53, p < 0.05) and between days 51 and 100 in group B (r = -0.76, p< 0.05). Conclusions: These data suggest the appreciable EPO production in premature infants, but its insufficient response to the depressed hemoglobin level, implying the need to administer exogenous EPO to infants with anemia of prematurity.

AB - Purpose: To evaluate the kinetics of erythropoietin (EPO) production and address the pathogenesis of anemia of prematurity, we measured EPO levels in infants during the first year of life. Patients and Methods: Using a radioimmunoassay, serum EPO levels were measured in 97 infants classified into three groups according to weight: group A, n = 40, < 1,500 g; group B, n = 19, 1,500–2,499 g; and group C, n = 38, × 2,500 g. Results: The serum EPO level ranged widely during the early neonatal period from days 0 to 6 (group A, <5 to 307 mU/ml; group B, 10–340 mU/ml; and group C, 9–108 mU/ml). EPO reached its lowest level (<20 mU/ml) between days 7 and 50 in all groups. The hemoglobin concentration reached its nadir between days 51 and 150 in all groups, with the lowest concentration observed in low birth weight infants. In contrast, the EPO level during the anemic phase was ∼20 mU/ml and was independent of birth weight. A negative correlation between serum EPO level and hemoglobin concentration was observed only in group C (r = -0.54, p < 0.05). The negative slope of the regression equation in group C exceeded that of groups A and B (p < 0.05). When the relationship between EPO and Hb was evaluated over periods of 7–50 days, 51–100 days, and >101 days, respectively, we noted a significant correlation between values on days 7 and 50 in group A (r = -0.53, p < 0.05) and between days 51 and 100 in group B (r = -0.76, p< 0.05). Conclusions: These data suggest the appreciable EPO production in premature infants, but its insufficient response to the depressed hemoglobin level, implying the need to administer exogenous EPO to infants with anemia of prematurity.

UR - http://www.scopus.com/inward/record.url?scp=0028303808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028303808&partnerID=8YFLogxK

U2 - 10.1097/00043426-199408000-00005

DO - 10.1097/00043426-199408000-00005

M3 - Article

VL - 16

SP - 213

EP - 218

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -